<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The prevalence of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was determined prospectively in patients presenting with <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>An attempt was made to define a subset of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients at risk for this syndrome on the basis of their clinical features </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: Fifty-one consecutive patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> were assessed </plain></SENT>
<SENT sid="3" pm="."><plain>Tests used for the laboratory diagnosis of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> included four <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent coagulation tests for detection of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and two enzyme-linked immunosorbent assays for antibodies to <z:chebi fb="0" ids="16247">phospholipid</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Three of 51 patients (6%, 95% confidence intervals 0% to 12.0%) had a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and the clinical features of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Seven patients had clinical features suggestive of the syndrome but negative laboratory tests </plain></SENT>
<SENT sid="6" pm="."><plain>Those patients who were clinically unlikely to have this syndrome also had negative laboratory tests </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: In a series of 51 unselected patients presenting with <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>, three had the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The clinical features of this syndrome are helpful in identifying this group of patients </plain></SENT>
<SENT sid="9" pm="."><plain>The role of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in the pathogenesis of <z:hpo ids='HP_0001297'>stroke</z:hpo> remains to be defined </plain></SENT>
</text></document>